Stock Shock: The Unpredictable Rise and Fall of CETX—What’s Driving the Drama?
Cemtrex Inc (CETX) Stock Trading Recap On Friday, Cemtrex Inc (CETX) stock saw a decline, ending the day at $0.11 which represents a decrease of $-0.09 or -45.00% from the prior close of $0.2. The stock opened at $0.14 and touched a low of $0.11 during the day, reaching a high of $0.14. The volume […]
ENSC Unveiled: The Shocking Truth Behind Ensysce Biosciences Inc’s Latest Stock Movements
Ensysce Biosciences Inc (ENSC) Stock Trading Recap On Friday, Ensysce Biosciences Inc (ENSC) stock saw a decline, ending the day at $0.43 which represents a decrease of $-0.16 or -27.12% from the prior close of $0.59. The stock opened at $0.56 and touched a low of $0.42 during the day, reaching a high of $0.56. […]
The Citius Pharmaceuticals Inc Rollercoaster: What’s Behind the Latest CTXR Stock Fluctuation?
Citius Pharmaceuticals Inc (CTXR) Stock Trading Recap On Friday, Citius Pharmaceuticals Inc (CTXR) stock saw a decline, ending the day at $0.13 which represents a decrease of $-0.04 or -23.53% from the prior close of $0.17. The stock opened at $0.13 and touched a low of $0.11 during the day, reaching a high of $0.15. […]
The SAVA Stock Mystery: Why Did SAVA Plunge Today?
H.C. Wainwright has recently raised Cassava Sciences Inc (SAVA) stock to Buy rating, as announced on October 8, 2024, according to Finviz. Earlier, on July 1, 2024, H.C. Wainwright had reduced the stock from a Buy to Neutral. B. Riley Securities also reduced Neutral rating with a price target of $44. Additionally, Cantor Fitzgerald reduced […]
Luminar Technologies Inc (LAZR) Stock Posted a Gross Margin of -79.62% Over the Past Year: Is This Justifiable?
Deutsche Bank has recently resumed Luminar Technologies Inc (LAZR) stock to Hold rating, as announced on September 10, 2024, according to Finviz. Earlier, on April 10, 2024, BofA Securities had reduced the stock from a Neutral to Underperform, setting a price target of $1.20 for LAZR stock. Deutsche Bank also reduced Hold rating with a […]
Why Crown Electrokinetics Corp. (CRKN) Stock is Currently -28.45% Off from Its 20-Day SMA?
Crown Electrokinetics Corp. (CRKN) Stock Trading Recap On Friday, Crown Electrokinetics Corp. (CRKN) stock saw a decline, ending the day at $0.66 which represents a decrease of $-0.14 or -17.50% from the prior close of $0.8. The stock opened at $0.83 and touched a low of $0.63 during the day, reaching a high of $0.94. […]
Lineage Cell Therapeutics Inc (LCTX) Stock Settles at $0.5: What’s Contributing to This Price Point?
Craig Hallum has recently initiated Lineage Cell Therapeutics Inc (LCTX) stock to Buy rating, as announced on August 20, 2024, according to Finviz. Earlier, on November 2, 2022, Robert W. Baird had initiated the stock to Outperform, setting a price target of $5. B. Riley Securities also initiated Buy rating with a price target of […]
CERo Therapeutics Holdings Inc (CERO) Stock Price Reaches $0.22: What Factors Are Influencing This Level?
CERo Therapeutics Holdings Inc (CERO) Stock Trading Recap On Friday, CERo Therapeutics Holdings Inc (CERO) stock saw a decline, ending the day at $0.22 which represents a decrease of $-0.03 or -12.00% from the prior close of $0.25. The stock opened at $0.23 and touched a low of $0.21 during the day, reaching a high […]
Molecular Templates Inc (MTEM) Stock Sees Market Value Hit $2.21 million: What Are the Implications?
BofA Securities has recently initiated Molecular Templates Inc (MTEM) stock to Buy rating, as announced on April 21, 2021, according to Finviz. Earlier, on February 1, 2021, UBS had initiated the stock to Neutral, setting a price target of $13. Jefferies also initiated Buy rating with a price target of $21. Additionally, Stifel initiated Buy […]
What Factors Have Led to Pyxis Oncology Inc (PYXS) Stock Trading -72.26% Below Its 52-Week High?
William Blair has recently reduced Pyxis Oncology Inc (PYXS) stock to Mkt Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on November 8, 2024, Stephens had initiated the stock to Overweight, setting a price target of $13. Stifel also initiated Buy rating with a price target of $10. Additionally, Jefferies resumed […]